Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

Transplantation Society International CMV Consensus Group

Research output: Contribution to journalArticle

496 Scopus citations


Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.

Original languageEnglish (US)
Pages (from-to)333-360
Number of pages28
Issue number4
StatePublished - Aug 27 2013



  • CMV
  • Cytomegalovirus
  • Ganciclovir
  • Prevention
  • Prophylaxis
  • Resistance
  • Treatment
  • Valganciclovir

ASJC Scopus subject areas

  • Transplantation

Cite this